Drug Use During Sex and Its Impact on Taking PrEP (Pre-Exposure Prophylaxis) : CONSUME

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-18

Study Completion Date

2022-03-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a cross-sectional, single-center observational study conducted from October 2020 to March 2021 in Ile de France at the infectious disease of CHU Bichat (PrEP and CeGIDD(Free Center for Information, Screening and Diagnosis of Infections by Human Immunodeficiency Viruses, Viral Hepatitis and Sexually Transmitted Infections) consultation). It concerns adult subjects of male or transgender sex, of MSM (men having sex with men) or bi-sexual orientation. The data are collected by self-questionnaire evaluating the consumption of Chemsex (drug use in a sexual context) over the last 12 months, the existence or not of addiction treatment, the history of STIs (sexually transmitted infections) and adherence to PrEP (for subjects taking PrEP) during the last sexual intercourse (ANRS questionnaire, used in the PREVENIR study).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Self-Consent for PrEP Perspectives

NCT02801760

HIV PrEP

COMPLETED

Factors Affecting PrEP Adherence

NCT02411630

HIV Infection

COMPLETED

HIV Prevention During Chemsex

NCT03956758

Men Having Sex With Other Men

WITHDRAWN

Transgender Youth and PrEP: PK, Safety, Uptake & Adherence - Demonstration Project

NCT04077151

HIV/AIDS Gender Behavior and Behavior Mechanisms

COMPLETED NA

Pre-Exposure Prophylaxis in YMSM

NCT01033942

HIV

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug Dependence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

male or transgender patients

of sexual orientation MSM (men having sex with men) or bi-sexual, consultant in sexual health centers

self-questionnaire

Intervention Type BEHAVIORAL

self-questionnaire assessing Chemsex's (drug use in a sexual context) consumption over the last 12 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

self-questionnaire

self-questionnaire assessing Chemsex's (drug use in a sexual context) consumption over the last 12 months

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age\> 18
* male or transgender
* MSM or bi-sexual orientation
* adult consultant at Bichat Hospital (CeGIDD or PrEP consultation)
* adult with a Smartphone (online self-questionnaire)